Evidence map›Paper›PMID 33452336›Full record

ArticleScientific reports2021

Estimating the health burden of aflatoxin attributable stunting among children in low income countries of Africa.

Hifza Rasheed, Ya Xu, Martin E Kimanya, Xiaoxi Pan, Zhihua Li, Xiaobo Zou, Candida P Shirima, Melvin Holmes, Michael N Routledge, Yun Yun Gong

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Keeping toxigenicFrontiers in microbiology · 2024
    Article
  16. Article
  17. Article
  18. Aflatoxin BInsects · 2022
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Hifza RasheedSchool of Food Science and Nutrition, University of Leeds, Leeds, UK.
Ya XuSchool of Medicine, University of Leeds, Leeds, LS2 9JT, UK.
Martin E KimanyaSchool of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, P. O. Box 447, Arusha, Tanzania.
Xiaoxi PanSchool of Medicine, University of Leeds, Leeds, LS2 9JT, UK.
Zhihua LiSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang, China.
Xiaobo ZouSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang, China.
Candida P ShirimaTanzania Bureau of Standards (TBS), P. O. Box 9524, Dar es Salaam, Tanzania.
Melvin HolmesSchool of Food Science and Nutrition, University of Leeds, Leeds, UK.
Michael N RoutledgeSchool of Medicine, University of Leeds, Leeds, LS2 9JT, UK. medmnr@leeds.ac.uk.
Yun Yun GongSchool of Food Science and Nutrition, University of Leeds, Leeds, UK. medyg@leeds.ac.uk.
University of Leeds · GBJiangsu University · CNNelson Mandela African Institution of Science and Technology · TZPakistan Council of Research in Water Resources · PKTanzania Bureau of Standards

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous population-based studies have documented high prevalence of aflatoxin associated childhood stunting in low income countries. We provide an estimate of the disease burden of aflatoxin related stunting using data from the four African countries. For this empirical analysis, we obtained blood aflatoxin albumin adduct biomarker based exposure data as measured using ELISA technique and anthropometric measurement data from surveys done over a 12-year period from 2001 to 2012 in four low income countries in Africa. We used these data to calculate population attributable risk (PAR), life time disease burden for children under five by comparing two groups of stunted children using both prevalence and incidence-based approaches. We combined prevalence estimates with a disability weight, measuring childhood stunting and co-occurrence of stunting-underweight to produce years lived with disability. Using a previously reported mortality, years of life lost were estimated. We used probabilistic analysis to model these associations to estimate the disability-adjusted life-years (DALYs), and compared these with those given by the Institute for Health Metrics and Evaluation's Global Burden of Disease (GBD) 2016 study. The PAR increased from 3 to 36% for aflatoxin-related stunting and 14-50% for co-occurrence of stunting and underweight. Using prevalence-based approach, children with aflatoxin related stunting resulted in 48,965.20 (95% uncertainty interval (UI): 45,868.75-52,207.53) DALYs per 100,000 individuals. Children with co-occurrence of stunting and underweight due to exposure to aflatoxin resulted in 40,703.41 (95% UI: 38,041.57-43,517.89) DALYs per 100,000 individuals. Uncertainty analysis revealed that reducing aflatoxin exposure in high exposure areas upto non-detectable levels could save the stunting DALYs up to 50%. The burden of childhood all causes stunting is greater in countries with higher aflatoxin exposure such as Benin. In high exposure areas, these results might help guide research protocols and prioritisation efforts and focus aflatoxin exposure reduction. HEFCE Global Challenge Research Fund Aflatoxin project.

Indexed as

Cost of IllnessAflatoxinsAlbuminsBeninChild, PreschoolFemaleGambiaGrowth DisordersHumansInfantMaleQuality-Adjusted Life YearsRisk FactorsTanzaniaTogoaflatoxin-albumin adductAflatoxinsAlbumins

Identifiers

PMID33452336
PMCPMC7810982
OpenAlexW3124279031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.